Hong Kong SAR

Hybrid electric vehicle maker Li Auto received the go ahead from Hong Kong’s stock exchange for a secondary listing.

Hong Kong’s stock exchange has rejected an IPO application from Aim Vaccine, a leading Chinese vaccine maker. The deal is being sponsored by China Securities, CICC, Goldman Sachs and Macquarie.

Having your CV stand out in a sea of job applications is no easy feat. So how do you grab an employer's attention?

Financial services company Far East Horizon has raised $200m from a convertible bond, its second CB in as many months.

A leading shareholder in WuXi Biologics (Cayman) has pocketed HK$10.3bn ($1.3bn) after offloading a chunk of the company’s shares.

CMB International has hired Branson Song, a veteran equity capital markets banker, as head of its ECM business.

Mizuho has lost another three loans bankers in Hong Kong, after a senior director left at the beginning of the year, according to a source close to the situation.

As Western companies operating in Hong Kong await the details of a warning from the US State Department about the risks of doing business in the special administrative region, analysts say the growing rift between China and the US is putting HSBC in an especially uncomfortable position.

JP Morgan has hired equity capital markets banker Jonathan Paul, the latest in a series of additions to its Asia Pacific ECM team.

China’s move to tighten its grip on overseas IPOs of technology companies could be a boon to a handful of other markets in Asia.

CLP Power Hong Kong's latest $300m bond offered a rare bit of stability in a volatile market, making the well-established borrower popular with investors — but only for the right price.

Hong Kong-based financial leasing company Far East Horizon raised Rmb500m ($77m) from a two year Panda bond in the domestic Chinese market at the end of last week.